Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RBR E3 ubiquitin ligases in tumorigenesis
Peter Wang, Xiaoming Dai, Wenxiao Jiang, et al.
Seminars in Cancer Biology (2020) Vol. 67, pp. 131-144
Closed Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors
Gabriel LaPlante, Wei Zhang
Cancers (2021) Vol. 13, Iss. 12, pp. 3079-3079
Open Access | Times Cited: 58
Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy
Jinxin Liu, Ting Chen, Shizhe Li, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 259-268
Closed Access | Times Cited: 44
The ubiquitin codes in cellular stress responses
Xiangpeng Sheng, Zhixiong Xia, Hanting Yang, et al.
Protein & Cell (2023) Vol. 15, Iss. 3, pp. 157-190
Open Access | Times Cited: 39
The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy
Bo Hou, Ting Chen, He Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Skp2: A critical molecule for ubiquitination and its role in cancer
Tianyang Feng, Ping Wang, Xiling Zhang
Life Sciences (2024) Vol. 338, pp. 122409-122409
Open Access | Times Cited: 12
RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic–nuclear shuttling in human triple‐negative breast cancer
Shu‐Mei Huang, Dongni Shi, Shuqin Dai, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access | Times Cited: 1
Post-translational regulations of PD-L1 and PD-1: Mechanisms and opportunities for combined immunotherapy
Xiaoming Dai, Yang Gao, Wenyi Wei
Seminars in Cancer Biology (2021) Vol. 85, pp. 246-252
Open Access | Times Cited: 53
Unconventional protein post-translational modifications: the helmsmen in breast cancer
Jiena Liu, Qin Wang, Yujuan Kang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34
JAK/STAT signaling and cellular iron metabolism in hepatocellular carcinoma: therapeutic implications
Bilal Rah, Nada Mazen Farhat, Mawieh Hamad, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3147-3157
Closed Access | Times Cited: 19
E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities
Qiang Zou, Meng Liu, Kewei Liu, et al.
Cellular Oncology (2023) Vol. 46, Iss. 3, pp. 545-570
Open Access | Times Cited: 17
E3 ubiquitin ligase RBCK1 confers ferroptosis resistance in pancreatic cancer by facilitating MFN2 degradation
Dan Su, Chen Ding, Ruobing Wang, et al.
Free Radical Biology and Medicine (2024) Vol. 221, pp. 136-154
Closed Access | Times Cited: 7
PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Modulating the Ubiquitin–Proteasome System: A Therapeutic Strategy for Autoimmune Diseases
Dhananjay Yadav, Ji Yeon Lee, Nidhi Puranik, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1093-1093
Open Access | Times Cited: 25
Anti‐tumour potential of PD‐L1 / PD ‐1 post‐translational modifications
Shimeng Zhou, Jinfeng Zhu, Jingwei Xu, et al.
Immunology (2022) Vol. 167, Iss. 4, pp. 471-481
Open Access | Times Cited: 24
RNF144A promotes antiviral responses by modulating STING ubiquitination
Bo Yang, Jinyong Pei, Lu Chen, et al.
EMBO Reports (2023) Vol. 24, Iss. 12
Open Access | Times Cited: 16
The E3 ubiquitin ligases regulate inflammation in cardiovascular diseases
Xiaohong Chen, Jia Ma, Zhiwei Wang, et al.
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 167-174
Closed Access | Times Cited: 14
Current and future directions of USP7 interactome in cancer study
Hong‐Beom Park, Kwang‐Hyun Baek
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188992-188992
Closed Access | Times Cited: 13
The emerging role of WWP1 in cancer development and progression
Xiaoli Hu, Jiangtao Yu, Zixia Lin, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 32
Taraxasterol acetate targets RNF31 to inhibit RNF31/p53 axis-driven cell proliferation in colorectal cancer
Chao‐Tao Tang, Jing Yang, Zide Liu, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 27
Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases
Yelin Jeong, Ah‐Reum Oh, Young Hoon Jung, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 10, pp. 2097-2104
Open Access | Times Cited: 12
The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability
Etna Abad, Jérémy Sandoz, Gerard Romero, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
Advances in designing ternary complexes: Integrating in-silico and biochemical methods for PROTAC optimisation in target protein degradation
Shareef Shaik, Prasanna Kumar Reddy Gayam, Manish Chaudhary, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107868-107868
Open Access | Times Cited: 4
Unraveling the role of deubiquitinating enzymes on cisplatin resistance in several cancers
S. Jin, Kwang‐Hyun Baek
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189297-189297
Closed Access
Molecular Mapping in Head and Neck Adenoid Cystic Carcinoma by Pathological Grade Using Whole-exome Sequencing and Spatial Transcriptome
Yuelu Zhu, Li Lin, Shun Wang, et al.
Human Pathology (2025), pp. 105758-105758
Closed Access
E3 ubiquitin ligases and their therapeutic potential in disease Management
Geet Madhukar, Md Azizul Haque, Shawez Khan, et al.
Biochemical Pharmacology (2025), pp. 116875-116875
Closed Access
Page 1 - Next Page

Scroll to top